Cargando…

Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy

There exists an urgent medical demand at present to develop therapeutic strategies which can improve the treatment outcome of hepatocellular carcinoma (HCC). Here, we explore the biological functions and clinical significance of PBOV1 in HCC in order to push forward the diagnosis and treatment of HC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yu, Wu, Zhiqiang, Shen, Shunli, Guo, Ruomi, Wang, Jing, Wang, Weiwei, Zhao, Kun, Kuang, Ming, Shuai, Xintao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109108/ https://www.ncbi.nlm.nih.gov/pubmed/30143633 http://dx.doi.org/10.1038/s41467-018-05764-7

Ejemplares similares

Development of a Non‐Coding‐RNA‐based EMT/CSC Inhibitory Nanomedicine for In Vivo Treatment and Monitoring of HCC
por: Guo, Ruomi, et al.
Publicado: (2019)

PBOV1 promotes prostate cancer proliferation by promoting G(1)/S transition
por: Pan, Tiejun, et al.
Publicado: (2016)

Nanomedicine promotes ferroptosis to inhibit tumour proliferation in vivo
por: Luo, Yifeng, et al.
Publicado: (2021)

lncRNA NTT/PBOV1 Axis Promotes Monocyte Differentiation and Is Elevated in Rheumatoid Arthritis
por: Yang, Chin-An, et al.
Publicado: (2018)

Celastrol-based nanomedicine promotes corneal allograft survival
por: Li, Zhanrong, et al.
Publicado: (2021)

FBXL19-AS1 promotes the progression of nasopharyngeal carcinoma by acting as a competing endogenous RNA to sponge miR-431 and upregulate PBOV1
por: Dong, Hongjun, et al.
Publicado: (2021)

PBOV1 Is a Human De Novo Gene with Tumor-Specific Expression That Is Associated with a Positive Clinical Outcome of Cancer
por: Samusik, Nikolay, et al.
Publicado: (2013)

Theranostic Nanomedicine for Synergistic Chemodynamic Therapy and Chemotherapy of Orthotopic Glioma
por: Tan, Junyi, et al.
Publicado: (2020)

Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma
por: Shen, Rui, et al.
Publicado: (2022)

Somatic Mutation Profiles Revealed by Next Generation Sequencing (NGS) in 39 Chinese Hepatocellular Carcinoma Patients
por: Ke, Lixin, et al.
Publicado: (2022)

Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis
por: Shen, Shunli, et al.
Publicado: (2018)

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2022)

Exploiting targeted nanomedicine for surveillance, diagnosis, and treatment of hepatocellular carcinoma
por: Liu, Tingting, et al.
Publicado: (2023)

Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma
por: Ladju, Rusdina Bte, et al.
Publicado: (2017)

Intracellular Reduction-Responsive Molecular Targeted Nanomedicine for Hepatocellular Carcinoma Therapy
por: Ding, Lei, et al.
Publicado: (2022)

Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment
por: Bakrania, Anita, et al.
Publicado: (2021)

Correction to: Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2023)

Polylactide-tethered prodrugs in polymeric nanoparticles as reliable nanomedicines for the efficient eradication of patient-derived hepatocellular carcinoma
por: Wang, Hangxiang, et al.
Publicado: (2018)

Comparison of clinical efficacy between LAPS and ALPPS in the treatment of hepatitis B virus-related hepatocellular carcinoma
por: Chen, Zebin, et al.
Publicado: (2023)

Bimodal Imaging‐Visible Nanomedicine Integrating CXCR4 and VEGFa Genes Directs Synergistic Reendothelialization of Endothelial Progenitor Cells
por: Yu, Bingbo, et al.
Publicado: (2020)

Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients
por: Zhaohui, Zhang, et al.
Publicado: (2019)

Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma
por: Ladju, Rusdina Bte, et al.
Publicado: (2018)

Promoting the bench-to-bedside translation of nanomedicines
por: Zhang, Ning
Publicado: (2023)

NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition
por: Zhang, Yi, et al.
Publicado: (2018)

Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation
por: Xiao, Zecong, et al.
Publicado: (2022)

Synergistic Nanomedicine: Photodynamic, Photothermal and Photoimmune Therapy in Hepatocellular Carcinoma: Fulfilling the Myth of Prometheus?
por: Ailioaie, Laura Marinela, et al.
Publicado: (2023)

Temperature sensitive liposome based cancer nanomedicine enables tumour lymph node immune microenvironment remodelling
por: Fu, Shunli, et al.
Publicado: (2023)

Nanomedicine
por: Howard, Kenneth A, et al.
Publicado: (2016)

Role of macrophage in nanomedicine-based disease treatment
por: Song, Siwei, et al.
Publicado: (2021)

Emerging Anesthetic Nanomedicines: Current State and Challenges
por: Zhang, Shuo, et al.
Publicado: (2023)

Heme oxygenase-1 alleviates advanced glycation end product-induced oxidative stress, inflammatory response and biological behavioral disorders in rat dermal fibroblasts
por: Li, Qingling, et al.
Publicado: (2021)

Therapeutic polymeric nanomedicine: GSH-responsive release promotes drug release for cancer synergistic chemotherapy
por: Shen, Jie, et al.
Publicado: (2019)

The role of associating liver partition and portal vein ligation for staged hepatectomy in unresectable hepatitis B virus-related hepatocellular carcinoma
por: Ke, Lixin, et al.
Publicado: (2020)

Discriminative pattern of reduced cerebral blood flow in Parkinson’s disease and Parkinsonism-Plus syndrome: an ASL-MRI study
por: Cheng, Lina, et al.
Publicado: (2020)

Nanomedicine for Ischemic Stroke
por: Dong, Xinyue, et al.
Publicado: (2020)

Multifunctional phototheranostic nanomedicine for cancer imaging and treatment
por: Gao, D., et al.
Publicado: (2019)

Nanomedicines for the Efficient Treatment of Intracellular Bacteria: The “ART” Principle
por: Qi, Hongzhao, et al.
Publicado: (2021)

Nanomedicine in cancer therapy
por: Fan, Dahua, et al.
Publicado: (2023)

Immunogenic-cell-killing and immunosuppression-inhibiting nanomedicine
por: Wang, Ying, et al.
Publicado: (2020)

Biomimetic nanomedicines for precise atherosclerosis theranostics
por: Tao, Ying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1qehu9ca1uahjud4enjkn91agd